AAAAAA
Results:
1-15
|
Results: 15
Authors:
Kol, S
Citation: S. Kol, Should we explore OHSS full clinical scope?..., HUM REPR, 16(3), 2001, pp. 595-596
Authors:
Kol, S
Citation: S. Kol, GnRH antagonists in ART: lower embryo implantation?, HUM REPR, 15(9), 2000, pp. 1881-1882
Authors:
Itskovitz-Eldor, J
Kol, S
Mannaerts, B
Citation: J. Itskovitz-eldor et al., Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report, HUM REPR, 15(9), 2000, pp. 1965-1968
Authors:
Kol, S
Itskovitz-Eldor, J
Citation: S. Kol et J. Itskovitz-eldor, Severe OHSS - Yes, there is a strategy to prevent it!, HUM REPR, 15(11), 2000, pp. 2266-2267
Authors:
Lewit, N
Kol, S
Citation: N. Lewit et S. Kol, The low responder female IVF patient with hypogonadotropic hypogonadism: do not give up!, FERT STERIL, 74(2), 2000, pp. 401-402
Authors:
Beloosesky, R
Kol, S
Lightman, A
Itskovitz-Eldor, J
Citation: R. Beloosesky et al., Ovarian stimulation in in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome, FERT STERIL, 74(1), 2000, pp. 166-168
Authors:
Kol, S
Wong, KHH
Ando, M
Ben-Shlomo, I
Adashi, EY
Citation: S. Kol et al., Rat ovarian interleukin-1 alpha - Interleukin-1-dependent in vitro expression, ENDOCRINE, 11(3), 1999, pp. 269-275
Authors:
Ando, M
Kol, S
Irahara, M
Sirois, J
Adashi, EY
Citation: M. Ando et al., Non-steroidal anti-inflammatory drugs (NSAIDs) block the late, prostanoid-dependent/ceramide-independent component of ovarian IL-1 action: implications for the ovulatory process, MOL C ENDOC, 157(1-2), 1999, pp. 21-30
Authors:
Kol, S
Ruutiainen-Altman, K
Scherzer, WJ
Ben-Shlomo, I
Ando, M
Rohan, RM
Adashi, EY
Citation: S. Kol et al., The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1 beta and of the type I and type IIIL-1 receptors, MOL C ENDOC, 149(1-2), 1999, pp. 115-128
Authors:
Kol, S
Lightman, A
Hillensjo, T
Devroey, P
Fauser, B
Tarlatzis, B
Mannaerts, B
Itskovitz-Eldor, J
Citation: S. Kol et al., High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles, HUM REPR, 14(9), 1999, pp. 2242-2244
Authors:
Coffler, MS
Kol, S
Drugan, A
Itskovitz-Eldor, J
Citation: Ms. Coffler et al., Early transvaginal embryo aspiration: a safer method for selective reduction in high order multiple gestations, HUM REPR, 14(7), 1999, pp. 1875-1878
Authors:
Lightman, A
Kol, S
Itskovitz-Eldor, J
Citation: A. Lightman et al., A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles, HUM REPR, 14(10), 1999, pp. 2596-2599
Authors:
Irahara, M
Ando, M
Kol, S
Adashi, EY
Citation: M. Irahara et al., Expression and hormonal regulation of rat ovarian interleukin-1 beta converting enzyme, a putative apoptotic marker: endocrine- and paracrine-dependence, J REPRO IMM, 45(1), 1999, pp. 67-79
Authors:
Derman, SG
Kol, S
Ben-Shlomo, I
Resnick, CE
Rohan, RM
Adashi, EY
Citation: Sg. Derman et al., Transforming growth factor-beta(1) is a potent inhibitor of interleukin-1 beta action in whole ovarian dispersates, J ENDOCR, 160(3), 1999, pp. 415-423
Authors:
Kol, S
Donesky, BW
Ruutiainen-Altman, K
Ben-Shlomo, I
Irahara, M
Ando, M
Rohan, RM
Adashi, EY
Citation: S. Kol et al., Ovarian interleukin-1 receptor antagonist in rats: Gene expression, cellular localization, cyclic variation, and hormonal regulation of a potential determinant of interleukin-1 action, BIOL REPROD, 61(1), 1999, pp. 274-282
Risultati:
1-15
|